Abstract
Forty-two 3-substituted 1-(5-formylfurfuryl)indolin-2-ones were synthesized and most of these compounds exhibited potent inhibitory activities against P. oryzae (MIC = 0.78-25 μg/mL) and human intestinal Caco-2 cells (IC50 = 0.19-9.42 μM). Eight compounds selected for further screening also showed inhibitory activities (IC50 = 1.84-10.32 μM) against human lung adenocarcinoma cells (SPC-A1).
Keywords: 3-Substituted 1-(5-formylfurfuryl)indolin-2-ones, antitumor activity, antifungal activity, Pyricoraria oryzae, Caco-2 cells, SPC-A1
Letters in Organic Chemistry
Title: Synthesis and Antitumor Activities of 3-Substituted 1-(5-formylfurfuryl)indolin-2-one Derivatives
Volume: 4 Issue: 8
Author(s): Fusheng Zhou, Jianbin Zheng, Xiaochun Dong, Zhiwen Zhang, Lingling Zhao, Xianyi Sha, Lin Li and Ren Wen
Affiliation:
Keywords: 3-Substituted 1-(5-formylfurfuryl)indolin-2-ones, antitumor activity, antifungal activity, Pyricoraria oryzae, Caco-2 cells, SPC-A1
Abstract: Forty-two 3-substituted 1-(5-formylfurfuryl)indolin-2-ones were synthesized and most of these compounds exhibited potent inhibitory activities against P. oryzae (MIC = 0.78-25 μg/mL) and human intestinal Caco-2 cells (IC50 = 0.19-9.42 μM). Eight compounds selected for further screening also showed inhibitory activities (IC50 = 1.84-10.32 μM) against human lung adenocarcinoma cells (SPC-A1).
Export Options
About this article
Cite this article as:
Zhou Fusheng, Zheng Jianbin, Dong Xiaochun, Zhang Zhiwen, Zhao Lingling, Sha Xianyi, Li Lin and Wen Ren, Synthesis and Antitumor Activities of 3-Substituted 1-(5-formylfurfuryl)indolin-2-one Derivatives, Letters in Organic Chemistry 2007; 4 (8) . https://dx.doi.org/10.2174/157017807782795484
DOI https://dx.doi.org/10.2174/157017807782795484 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Infrared Spectroscopy and Imaging in Cancer Diagnosis
Current Medicinal Chemistry Perinatal Gene Transfer to the Liver
Current Pharmaceutical Design Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis
Current Pharmaceutical Design Pharmacogenetics in Affective Disorders: A Drug Response Approach
Current Pharmacogenomics Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy NFAT Gene Family in Inflammation and Cancer
Current Molecular Medicine Significance of Metallothionein Expression in Liver Disease
Current Pharmaceutical Biotechnology The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Recent Patents on Anti-Cancer Drug Discovery Integrins Modulate Cellular Fibrogenesis at Multiple Levels: Regulation of TGF-β Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Pegylated Interferons for the Treatment of Chronic Hepatitis B
Recent Patents on Anti-Infective Drug Discovery Liposomes as siRNA Delivery Vectors
Current Drug Metabolism Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Current Drug Targets Stem Cells and the Side Population Theory: A Critical Review
Current Tissue Engineering (Discontinued) Multistep Renal Carcinogenesis in the Eker (Tsc 2 Gene Mutant) Rat Model
Current Molecular Medicine Artificial Intelligence Techniques for Colorectal Cancer Drug Metabolism: Ontologies and Complex Networks
Current Drug Metabolism Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery
Mini-Reviews in Medicinal Chemistry Nanomedicine to Overcome Cancer Multidrug Resistance
Current Drug Metabolism Formulation and Characterization of Rutin Loaded Chitosan-alginate Nanoparticles: Antidiabetic and Cytotoxicity Studies
Current Drug Delivery